Monarch Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Monarch Capital Management Inc

$397 Million
Q4 2025

A detailed history of Monarch Capital Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Monarch Capital Management Inc holds 3,119 shares of REGN stock, worth $2.16 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

3,119

Previous 2,915 7.0%

Holding current value

$2.16 Million

Previous $1.64 Million 31.97%

% of portfolio

0.54%

Previous 0.41%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 23, 2026	BUY	$557.73 - $694.99 $113,776 - $141,777	204 Added 7.0%	3,119 $2.16 Million
Q3 2025 Oct 20, 2025	BUY	$534.91 - $598.71 $304,898 - $341,264	570 Added 24.31%	2,915 $1.64 Million
Q2 2025 Aug 20, 2025	BUY	$483.07 - $625.6 $454,568 - $588,689	941 Added 67.02%	2,345 $1.23 Million
Q1 2025 Apr 15, 2025	BUY	$634.14 - $744.83 $213,705 - $251,007	337 Added 31.58%	1,404 $890,000
Q4 2024 Jan 15, 2025	BUY	$701.85 - $1046.91 $385,315 - $574,753	549 Added 105.98%	1,067 $760,000

Q3 2024 Oct 16, 2024	SELL	$1024.09 - $1201.76 $47,108 - $55,280	-46 Reduced 8.16%	518 $544,000
Q2 2024 Jul 24, 2024	SELL	$883.2 - $1071.19 $17,664 - $21,423	-20 Reduced 3.42%	564 $592,000
Q4 2023 Jan 17, 2024	SELL	$775.18 - $881.7 $22,480 - $25,569	-29 Reduced 4.73%	584 $512,000
Q3 2023 Nov 02, 2023	SELL	$692.45 - $844.37 $13,849 - $16,887	-20 Reduced 3.16%	613 $504,000
Q2 2023 Aug 01, 2023	SELL	$700.03 - $830.35 $10,500 - $12,455	-15 Reduced 2.31%	633 $454,000
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $2,117 - $2,299	-3 Reduced 0.46%	648 $0
Q3 2022 Oct 20, 2022	SELL	$573.97 - $724.32 $18,941 - $23,902	-33 Reduced 4.82%	651 $448,000
Q2 2022 Jul 20, 2022	SELL	$548.35 - $738.84 $2,741 - $3,694	-5 Reduced 0.73%	684 $404,000
Q1 2022 Apr 20, 2022	BUY	$595.12 - $698.43 $124,975 - $146,670	210 Added 43.84%	689 $481,000
Q4 2021 Jan 19, 2022	BUY	$543.48 - $670.97 $260,326 - $321,394	479 New	479 $302,000

Others Institutions Holding REGN

# of Institutions

1,501

Shares Held

86.6M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.

Account

Monarch Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History